These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 30989716)
1. BMP and mTOR signaling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities? Wu J; Ren B; Shi F; Hua P; Lin H J Cell Biochem; 2019 Aug; 120(8):12108-12122. PubMed ID: 30989716 [TBL] [Abstract][Full Text] [Related]
2. The HIF-1α and mTOR Pathways Amplify Heterotopic Ossification. Wang H; Kaplan FS; Pignolo RJ Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397384 [TBL] [Abstract][Full Text] [Related]
4. mTOR inhibition and BMP signaling act synergistically to reduce muscle fibrosis and improve myofiber regeneration. Agarwal S; Cholok D; Loder S; Li J; Breuler C; Chung MT; Sung HH; Ranganathan K; Habbouche J; Drake J; Peterson J; Priest C; Li S; Mishina Y; Levi B JCI Insight; 2016 Dec; 1(20):e89805. PubMed ID: 27942591 [TBL] [Abstract][Full Text] [Related]
5. Conserved signaling pathways underlying heterotopic ossification. Kan C; Chen L; Hu Y; Ding N; Lu H; Li Y; Kessler JA; Kan L Bone; 2018 Apr; 109():43-48. PubMed ID: 28455214 [TBL] [Abstract][Full Text] [Related]
6. Role of the NF-kB signalling pathway in heterotopic ossification: biological and therapeutic significance. Liu F; Zhao Y; Pei Y; Lian F; Lin H Cell Commun Signal; 2024 Mar; 22(1):159. PubMed ID: 38439078 [TBL] [Abstract][Full Text] [Related]
7. Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial. Pacifici M Bone; 2018 Apr; 109():267-275. PubMed ID: 28826842 [TBL] [Abstract][Full Text] [Related]
8. Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling. Wang H; Lindborg C; Lounev V; Kim JH; McCarrick-Walmsley R; Xu M; Mangiavini L; Groppe JC; Shore EM; Schipani E; Kaplan FS; Pignolo RJ J Bone Miner Res; 2016 Sep; 31(9):1652-65. PubMed ID: 27027798 [TBL] [Abstract][Full Text] [Related]
9. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva. Hino K; Horigome K; Nishio M; Komura S; Nagata S; Zhao C; Jin Y; Kawakami K; Yamada Y; Ohta A; Toguchida J; Ikeya M J Clin Invest; 2017 Sep; 127(9):3339-3352. PubMed ID: 28758906 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-κB Signaling-Mediated Crosstalk Between Macrophages and Preosteoblasts by Metformin Alleviates Trauma-Induced Heterotopic Ossification. Hou J; Chen J; Fan J; Tang Z; Zhou W; Lin H Inflammation; 2023 Aug; 46(4):1414-1429. PubMed ID: 37115368 [TBL] [Abstract][Full Text] [Related]
11. BMP Ligand Trap ALK3-Fc Attenuates Osteogenesis and Heterotopic Ossification in Blast-Related Lower Extremity Trauma. Strong AL; Spreadborough PJ; Dey D; Yang P; Li S; Lee A; Haskins RM; Grimm PD; Kumar R; Bradley MJ; Yu PB; Levi B; Davis TA Stem Cells Dev; 2021 Jan; 30(2):91-105. PubMed ID: 33256557 [TBL] [Abstract][Full Text] [Related]
13. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. de la Peña LS; Billings PC; Fiori JL; Ahn J; Kaplan FS; Shore EM J Bone Miner Res; 2005 Jul; 20(7):1168-76. PubMed ID: 15940369 [TBL] [Abstract][Full Text] [Related]
14. Metformin attenuates trauma-induced heterotopic ossification via inhibition of Bone Morphogenetic Protein signalling. Lin H; Shi F; Jiang S; Wang Y; Zou J; Ying Y; Huang D; Luo L; Yan X; Luo Z J Cell Mol Med; 2020 Dec; 24(24):14491-14501. PubMed ID: 33169942 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification. Felix-Ilemhenbhio F; Pickering GAE; Kiss-Toth E; Wilkinson JM Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805978 [TBL] [Abstract][Full Text] [Related]
16. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva. Ravazzolo R; Cappato S; Bocciardi R Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956 [TBL] [Abstract][Full Text] [Related]
17. Substance P signaling mediates BMP-dependent heterotopic ossification. Kan L; Lounev VY; Pignolo RJ; Duan L; Liu Y; Stock SR; McGuire TL; Lu B; Gerard NP; Shore EM; Kaplan FS; Kessler JA J Cell Biochem; 2011 Oct; 112(10):2759-72. PubMed ID: 21748788 [TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP). Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-selective allosteric destabilization of activin receptor-like kinases: A potential therapeutic avenue for prophylaxis of heterotopic ossification. Lu G; Tandang-Silvas MR; Dawson AC; Dawson TJ; Groppe JC Bone; 2018 Jul; 112():71-89. PubMed ID: 29626545 [TBL] [Abstract][Full Text] [Related]
20. Suppression of Overactive Insulin-Like Growth Factor 1 Attenuates Trauma-Induced Heterotopic Ossification in Mice. Mao D; Wang K; Jiang H; Mi J; Pan X; Zhao G; Rui Y Am J Pathol; 2024 Mar; 194(3):430-446. PubMed ID: 38101566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]